Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.42 | 2.27 |
NAV | ₹14.13 | ₹167.08 |
Fund Started | 03 Jan 2020 | 13 Oct 2005 |
Fund Size | ₹61.70 Cr | ₹1374.33 Cr |
Exit Load | For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.11% | 2.99% |
3 Year | 12.21% | 20.92% |
5 Year | 14.31% | 24.12% |
1 Year
3 Year
5 Year
Equity | 93.94% | 95.01% |
Cash | 6.06% | 4.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.84% |
Kotak Mahindra Bank Ltd. | 7.69% |
JSW Steel Ltd. | 7.11% |
Wipro Ltd. | 6.85% |
Indraprastha Gas Ltd. | 6.66% |
Biocon Ltd. | 6.57% |
UPL Ltd. | 5.38% |
HDFC Bank Ltd. | 4.60% |
PB Fintech Ltd. | 4.51% |
Info Edge (India) Ltd. | 4.29% |
Name | Assets |
---|---|
Infosys Ltd. | 8.83% |
ICICI Bank Ltd. | 6.77% |
Reliance Industries Ltd. | 6.47% |
HDFC Bank Ltd. | 5.24% |
NTPC Ltd. | 4.83% |
Bharti Airtel Ltd. | 4.81% |
Larsen & Toubro Ltd. | 4.31% |
Sun Pharmaceutical Industries Ltd. | 3.59% |
Dr. Reddy's Laboratories Ltd. | 3.04% |
Tata Consultancy Services Ltd. | 2.94% |
Name | Sailesh Jain | Sri Sharma |
Start Date | 05 May 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate medium to long-term capital appreciation by investing in equity and equity related instruments selected based on a quantitative model (Quant Model). | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 03 Jan 2020 | 13 Oct 2005 |
Description
Launch Date